171 related articles for article (PubMed ID: 30988043)
1. Low-dose methotrexate toxicity.
Pivovarov K; Zipursky JS
CMAJ; 2019 Apr; 191(15):E423. PubMed ID: 30988043
[No Abstract] [Full Text] [Related]
2. How should we manage low-dose methotrexate-induced pancytopenia in patients with rheumatoid arthritis?
Cansu DÜ; Teke HÜ; Bodakçi E; Korkmaz C
Clin Rheumatol; 2018 Dec; 37(12):3419-3425. PubMed ID: 30056523
[TBL] [Abstract][Full Text] [Related]
3. Pancytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthritis.
MacKinnon SK; Starkebaum G; Willkens RF
Semin Arthritis Rheum; 1985 Nov; 15(2):119-26. PubMed ID: 3877983
[TBL] [Abstract][Full Text] [Related]
4. Pancytopenia associated with low dose methotrexate therapy. A regional survey.
al-Awadhi A; Dale P; McKendry RJ
J Rheumatol; 1993 Jul; 20(7):1121-5. PubMed ID: 8371202
[TBL] [Abstract][Full Text] [Related]
5. [Suppression of bone marrow after drug interaction].
Spigset O; Messner T
Lakartidningen; 1993 Jun; 90(22):2138-40. PubMed ID: 8502067
[No Abstract] [Full Text] [Related]
6. Hazards of prolonged low-dose methotrexate therapy.
Bender AS
Va Med Mon (1918); 1970 Apr; 97(4):218-9. PubMed ID: 5317468
[No Abstract] [Full Text] [Related]
7. Severe pancytopenia in a patient taking low dose methotrexate and probenecid.
Basin KS; Escalante A; Beardmore TD
J Rheumatol; 1991 Apr; 18(4):609-10. PubMed ID: 2066953
[TBL] [Abstract][Full Text] [Related]
8. Folinic acid alleviates side effects of methotrexate in arthritis patients with side effects despite folic acid supplementation: an observational cohort study.
Fischer EA; Hetland ML; Krabbe S
Rheumatology (Oxford); 2020 Nov; 59(11):3566-3568. PubMed ID: 32591793
[No Abstract] [Full Text] [Related]
9. Leucovorin versus folic acid in the treatment of methotrexate toxicity: comment on the article by Shiroky et al.
Morgan SL; Baggott JE; Alarcón GS; Koopman WJ; Krumdieck CL
Arthritis Rheum; 1994 Mar; 37(3):444-5. PubMed ID: 8155177
[No Abstract] [Full Text] [Related]
10. A review of methotrexate-associated hepatotoxicity.
Bath RK; Brar NK; Forouhar FA; Wu GY
J Dig Dis; 2014 Oct; 15(10):517-24. PubMed ID: 25139707
[TBL] [Abstract][Full Text] [Related]
11. A Woman With Severe Rash.
Schall C; Cumpston KL; Lenczowski J; Wills BK
Ann Emerg Med; 2018 Aug; 72(2):128-165. PubMed ID: 30031506
[No Abstract] [Full Text] [Related]
12. Relationship between 5,10-methylenetetrahydrofolate reductase C677T gene polymorphism and methotrexate related toxicity in patients with autoimmune diseases receiving folic acid supplementation.
Speletas M; Papadopoulos N; Daiou C; Katodritou E; Pavlitou-Tsiontsi A; Galanopoulou V
Ann Rheum Dis; 2005 Dec; 64(12):1791-2. PubMed ID: 16284346
[No Abstract] [Full Text] [Related]
13. Methotrexate in the treatment of psoriasis.
Med Lett Drugs Ther; 1972 Jun; 14(12):41-2. PubMed ID: 4567562
[No Abstract] [Full Text] [Related]
14. Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review.
Prey S; Paul C
Br J Dermatol; 2009 Mar; 160(3):622-8. PubMed ID: 18945303
[TBL] [Abstract][Full Text] [Related]
15. Oral effects of low-dose methotrexate treatment.
Kalantzis A; Marshman Z; Falconer DT; Morgan PR; Odell EW
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Jul; 100(1):52-62. PubMed ID: 15953917
[TBL] [Abstract][Full Text] [Related]
16. Megaloblastic pancytopenia in a patient receiving concurrent methotrexate and trimethoprim-sulfamethoxazole treatment.
Maricic M; Davis M; Gall EP
Arthritis Rheum; 1986 Jan; 29(1):133-5. PubMed ID: 3484954
[No Abstract] [Full Text] [Related]
17. [Folic acid prevention of the adverse effects of methotrexate].
Szabó G; Mezei G
Fogorv Sz; 1984 Mar; 77(3):71-3. PubMed ID: 6608458
[No Abstract] [Full Text] [Related]
18. Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis: comment on the article by Gutierrez-Ureña et al.
Berthelot JM; Maugars Y; Prost A
Arthritis Rheum; 1997 Jan; 40(1):193-4; author reply 195-6. PubMed ID: 9008619
[No Abstract] [Full Text] [Related]
19. [Radiational basis and practice of the citrovorum factor (Leucovorin) protection after high-dose methotrexate therapy. High-dose methotrexate/leucovorin].
Sauer H; Schalhorn A
Onkologie; 1980 Apr; 3(2):64-71. PubMed ID: 6994007
[TBL] [Abstract][Full Text] [Related]
20. The value of methotrexate in dermatomyositis.
Zieglschmid-Adams ME; Pandya A; Cohen SB; Sontheimer RD
J Am Acad Dermatol; 1998 Jan; 38(1):130-2. PubMed ID: 9448226
[No Abstract] [Full Text] [Related]
[Next] [New Search]
